- More research will probably done in the near future on the nickel catalyst.
- This is partially due to the fact that there is currently little research on nickel.
- This research will be geared towards understanding what conditions the nickel catalyst works the best under.
- More research will also be conducted on the palladium catalyst.
- This is not only because of its proven success rate, but also because we already know what conditions it works best under.
- All of the future research will aim at synthesizing isoxazolines as effective MIF inhibitors to be used to treat chronic inflammatory and autoimmune diseases, including diabetes and cancers.